PE20191491A1 - QUICK RELEASE COMPOSITION OF CINITAPRIDE AND SYMETICONE AND PROCESS TO PREPARE IT - Google Patents

QUICK RELEASE COMPOSITION OF CINITAPRIDE AND SYMETICONE AND PROCESS TO PREPARE IT

Info

Publication number
PE20191491A1
PE20191491A1 PE2019001412A PE2019001412A PE20191491A1 PE 20191491 A1 PE20191491 A1 PE 20191491A1 PE 2019001412 A PE2019001412 A PE 2019001412A PE 2019001412 A PE2019001412 A PE 2019001412A PE 20191491 A1 PE20191491 A1 PE 20191491A1
Authority
PE
Peru
Prior art keywords
cinitapride
symeticone
prepare
quick release
release composition
Prior art date
Application number
PE2019001412A
Other languages
Spanish (es)
Inventor
Jose Luis Lauria
Original Assignee
Rhein Siegfried Sa De Cv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhein Siegfried Sa De Cv filed Critical Rhein Siegfried Sa De Cv
Publication of PE20191491A1 publication Critical patent/PE20191491A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a una composicion farmaceutica de administracion oral, bajo la forma de capsulas con contenido liquido, que comprende una combinacion a dosis fija de Cinitaprida tartrato y Simeticona junto con al menos un agente surfactante y opcionalmente uno o mas excipientes farmaceuticamente aceptables, y el proceso para obtener dicha composicion.The present invention relates to a pharmaceutical composition for oral administration, in the form of capsules with liquid content, which comprises a combination at a fixed dose of Cinitapride tartrate and Simethicone together with at least one surfactant agent and optionally one or more pharmaceutically acceptable excipients, and the process for obtaining said composition.

PE2019001412A 2017-02-07 2018-01-29 QUICK RELEASE COMPOSITION OF CINITAPRIDE AND SYMETICONE AND PROCESS TO PREPARE IT PE20191491A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MX2017001714A MX2017001714A (en) 2017-02-07 2017-02-07 Rapid-release composition of cinitapride and simeticone and method for preparing same.
PCT/IB2018/050528 WO2018146575A1 (en) 2017-02-07 2018-01-29 Rapid-release composition of cinitapride and simeticone and method for preparing same

Publications (1)

Publication Number Publication Date
PE20191491A1 true PE20191491A1 (en) 2019-10-21

Family

ID=63108046

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2019001412A PE20191491A1 (en) 2017-02-07 2018-01-29 QUICK RELEASE COMPOSITION OF CINITAPRIDE AND SYMETICONE AND PROCESS TO PREPARE IT

Country Status (10)

Country Link
AR (1) AR110797A1 (en)
BR (1) BR112019015989A2 (en)
CL (1) CL2019001944A1 (en)
CO (1) CO2019008347A2 (en)
CR (1) CR20190402A (en)
DO (1) DOP2019000190A (en)
EC (1) ECSP19051198A (en)
MX (1) MX2017001714A (en)
PE (1) PE20191491A1 (en)
WO (1) WO2018146575A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6676933B2 (en) * 2001-05-23 2004-01-13 Osmotica Corp. Pharmaceutical composition containing mosapride and pancreatin
WO2004071374A2 (en) * 2003-02-11 2004-08-26 Torrent Pharmaceuticals Limited Once a day orally administered pharmaceutical compositions
KR20070084531A (en) * 2004-11-24 2007-08-24 머크 앤드 캄파니 인코포레이티드 Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide
WO2009066146A2 (en) * 2007-11-19 2009-05-28 Cadila Pharmaceuticals Ltd. Stable solutions of sparingly soluble actives

Also Published As

Publication number Publication date
WO2018146575A1 (en) 2018-08-16
BR112019015989A2 (en) 2020-03-31
CR20190402A (en) 2019-09-20
DOP2019000190A (en) 2019-10-15
CO2019008347A2 (en) 2019-08-30
ECSP19051198A (en) 2019-07-31
MX2017001714A (en) 2018-08-06
CL2019001944A1 (en) 2019-12-06
AR110797A1 (en) 2019-05-02

Similar Documents

Publication Publication Date Title
CL2015003072A1 (en) Long-term colchicine release formulations and methods of use thereof.
CL2018002727A1 (en) Medicine obtained by combining agonist fxr and arb
MX2021010359A (en) Pharmaceutical composition used for reducing localised fat and use of pharmaceutical composition.
ECSP16084317A (en) PHARMACEUTICAL FORMULATIONS, PREPARATION PROCESSES AND METHODS OF USE
CL2019002218A1 (en) Triple combination formulations and methods to treat or reduce the risk of cardiovascular disease.
BR112018015367A2 (en) nanofiber oromucosal carriers for therapeutic treatment
CL2016002560A1 (en) Oral solid pharmaceutical dosage form comprising siponimod, a moisture protective agent and optionally a pharmaceutical excipient; Preparation procedure
CO2019002245A2 (en) Fxr agonist combination
CL2018003682A1 (en) Oral pharmaceutical composition, comprising a pharmaceutically active agent, at least one bioadhesive cationic polymer and at least two anionic polymers.
PH12018502524A1 (en) Physiologically balanced injectable formulations of fosnetupitant
CR20170125A (en) SOLID PHARMACEUTICAL COMPOSITION INCLUDING AMLODIPINA AND LOSARTÁN
MX2015003956A (en) Pharmaceutical composition comprising micronized pinaverium bromide and simeticone.
PE20191491A1 (en) QUICK RELEASE COMPOSITION OF CINITAPRIDE AND SYMETICONE AND PROCESS TO PREPARE IT
PE20160245A1 (en) STABLE ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION IN A FORM OF A DISPERSABLE TABLET INCLUDING ISONIAZID GRANULES AND RIFAPENTINE GRANULES AND THEIR PREPARATION PROCESS
ECSP16005208A (en) STABLE ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET INCLUDING ISONIAZID GRANULES AND RIFAPENTINE GRANULES AND THEIR PREPARATION PROCESS
AR099330A1 (en) USE OF PARICALCITOL IN THE TREATMENT OF INFLAMMATORY ANEMIA
CO2019006693A2 (en) Improved composition of lansoprazole and simethicone and process to prepare it
CR20190401A (en) Dropropizine in combination with ambroxol in the dosage form of syrup or tablets
IN2013MU02015A (en)
AR114006A1 (en) PHARMACEUTICAL COMBINATION IN THE FORM OF TWO-LAYER TABLETS THAT INCLUDE KETOROLACO TROMETAMINE AND TRAMADOL HYDROCHLORIDE, AND ITS USE FOR THE TREATMENT OF PAIN
CL2019001046A1 (en) Combination therapy that includes an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancer. (divisional application 201601131)
ECSP16086746A (en) IMMUNOSUPPRESSOR FORMULATION
CU20130165A7 (en) MODIFIED RELEASE OF 4-METHYL-3 - [[- 4- (3- PIRIDINIL) -2-PYRIMIDINYL] AMINO] -N-5- (4- METHYL-1H-IMIDAZOL-1- IL) -3- (TRIFLUOROMETIL) FENIL] SOLUBILIZED BENZAMIDE USING ORGANIC ACIDS
UA97982U (en) DRESSING MEDICINE FOR TABLETS
UA91282U (en) Drug formulation possessing pronounced antigestagenic activity